Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Meeting the Challenge of Male and Female Infertility: Make the First Step a Natural Approach
  • USA - English


News provided by

Ross Communications Inc.

Jul 19, 2017, 05:00 ET

Share this article

Share toX

Share this article

Share toX

Florham Park, NJ (PRWEB) July 19, 2017 -- A new non-prescription male fertility support supplement, Evolution60™, is now available from the makers of Pregnitude®, a doctor recommended fertility support dietary supplement for women, Exeltis USA, Inc. announced today. Numerous clinical studies support the demonstrated benefits of both Evolution60 and Pregnitude, respectively. (1,2,3,4,5)

In in the US alone, nearly 7 million couples struggle with infertility-which can affect the woman, man or both partners (6). The male partner is either the sole cause or a contributing cause in infertility in approximately forty percent of infertile couples. (7) "A couple is not considered infertile until they have been trying to have a baby for at least six months if they are over 35 or for couples under 35, they must be trying for at least one year before a diagnosis of infertility is confirmed," said Michael Krychman MD, a board-certified obstetrician and gynecologist in Newport, CA. "Many factors can cause infertility in women and men and in my opinion, couples who are currently having difficulty getting pregnant should get a medical evaluation and consider trying non-prescription, natural therapies such as Pregnitude and Evolution60, before they move forward with invasive medical therapies."

"In women, a common cause of infertility is Polycystic Ovary Syndrome (PCOS)- a hormonal imbalance that can cause irregular and sometimes no ovulation," said Dr. Krychman. The PCOS Foundation reports that PCOS may be responsible for 70 percent of infertility issues in women who have difficulty ovulating (8). Clinical studies demonstrate that taking a combination of myo-inositol (a naturally occurring substance produced by the human body from glucose), and folic acid (a B vitamin that promotes cell growth) in therapeutic doses can promote menstrual regularity, ovulatory function and higher quality eggs (4,5). "If a patient is having trouble getting pregnant due to cycle irregularity, I'll first recommend that she should consider trying Pregnitude, which contains these ingredients in therapeutic doses. Women and men should always consult with their physician before taking any vitamins or dietary supplements and should get proper medical work ups if fertility concerns are problematic," said Dr. Krychman.

Reduced male fertility can occur with increased age, lifestyle, environmental factors and certain medical conditions which can affect changes in male physiology and reproductive health (7). Evolution60 supplies important nutrients clinically shown to benefit male reproductive health, including: myo-inositol, selenium, folic acid, Vitamin E, L-carnitine and L-Arginine (1,2,,3).

"We're excited to bring an expanded portfolio of innovative OTC products to the U.S. market," said Eduardo Fernandez, VP of Operations at Exeltis USA, Inc. with expertise in the dietary supplement arena. "These products have an established base in Europe and will help meet the US. demand for ways to achieve optimal health."

  • For more information about Pregnitude, please visit: http://www.pregnitude.com
  • For more information about Evolution60, please visit: http://www.evolution60.com

About Exeltis USA, Inc.
Exeltis USA, Inc. is committed to improving women's health at all stages of life and offers an extensive portfolio of products. For more information, please visit: http://womenshealth.exeltisusa.com/

References
1. European Review for Medical and Pharmacological Sciences, Effects of myinositol on sperm mitochondrial function in-vitro, R.A. Condorelli, S. LaVignera, et al, 2011; 15: 129-134
2. Human Reproduction Update, Reproductive functions of the ageing male, B. Kubnert, E. Nieschlag, 2004, Vol. 10, No.4, pp327-339
3. Urology, Myoinositol: Does it improve sperm mitochondrial function and sperm motility? R. Condorelli, S. LaVignera, et al., 79 (6), pp 1290-1295, 2012
4. Randomized, double-blind placebo-controlled trial: Effects of Myo-inositol on Ovarian Function and Metabolic Factors in Women with PCOS; S Gerli et al: European Review for Medical and Pharmacological Sciences,
5. Effects of Myo-inositol Supplementation on Oocytes Quality in PCOS Patients:A Double-blind Trial; L. Ciotta et al: European Review for Medical and Pharmacological Sciences, 2011U.S.                      6. Department of Health and Human Services: https://www.hhs.gov/opa/reproductive-health/infertility/index.html
7. American Society for Reproductive Medicine: http://www.reproductivefacts.org/faqs/quick-facts-about-infertility
8. PCOS Foundation: http://www.pcosfoundation.org/PCOS-Education-trifold.pdf

Contact:
Barbara Ross
Ross Communications Inc.
bross(at)rosspr.com
201-236-1771

Barbara Ross, Ross Communications Inc., +1 (201) 236-1771, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.